1993
|
Sign up to set email alerts
Expression of human cytochrome P450 enzymes in yeast and bacteria and relevance to studies on catalytic specificity
Search citation statements
Order By: Relevance
Paper Sections
Select...
20
1
1
1
Citation Types
0
7
0
0
Year Published
Range
1995
19952019
2019Publication Types
Select...
18
3
2
Relationship
0
23
Authors
Journals
Cited by 23 publications
(7 citation statements)
References 39 publications
0
7
0
0
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…As C4H used in resveratrol pathway is a membrane-associated plant-derived P450 enzyme, which requires an electron carrier for optimal activity, we hypothesized that C4H activity may be limiting resveratrol production. Plant-derived P450s have previously been reported to poorly accept electrons directly from yeast endogenous electron carriers24. Thus, we upgraded the strain ST4978 (basic resveratrol pathway) with overexpression of cytochrome P450 reductase ( AtATR2 ) from A. thaliana or cytochrome B5 ( CYB5 ) from S. cerevisiae or both (Fig.…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…As C4H used in resveratrol pathway is a membrane-associated plant-derived P450 enzyme, which requires an electron carrier for optimal activity, we hypothesized that C4H activity may be limiting resveratrol production. Plant-derived P450s have previously been reported to poorly accept electrons directly from yeast endogenous electron carriers24. Thus, we upgraded the strain ST4978 (basic resveratrol pathway) with overexpression of cytochrome P450 reductase ( AtATR2 ) from A. thaliana or cytochrome B5 ( CYB5 ) from S. cerevisiae or both (Fig.…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In the E. coli expression system, this is, however, easily overcome by supplementing with eukaryotic NADPH cytochrome P450 reductases. The additional ability of the yeast system to perform post‐translational modifications of eukaryotic proteins is not a concern here as cytochromes P450 are generally not post‐translationally modified (Guengerich et al ., 1993). As a consequence thereof, catalytic specificity of cytochromes P450 have never been reported to be affected by post‐translational modification.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Tolbutamide is less potent than second-generation sulphonylureas such as glipizide and glyburide and it is not routinely used due to a higher incidence of adverse effects compared to newer second-generation sulfonylureas such as glyburide [1014]. Tolbutamide is mainly metabolized via methylhydroxylation by CYP2C9 to 4-OH-tolbutamide [968][969][970]1015] and thus is often used as a probe substrate for determining CYP2C9 activity (Fig. (123)).…”
Section: Tolbutamide
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…As C4H used in resveratrol pathway is a membrane-associated plant-derived P450 enzyme, which requires an electron carrier for optimal activity, we hypothesized that C4H activity may be limiting resveratrol production. Plant-derived P450s have previously been reported to poorly accept electrons directly from yeast endogenous electron carriers24. Thus, we upgraded the strain ST4978 (basic resveratrol pathway) with overexpression of cytochrome P450 reductase ( AtATR2 ) from A. thaliana or cytochrome B5 ( CYB5 ) from S. cerevisiae or both (Fig.…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In the E. coli expression system, this is, however, easily overcome by supplementing with eukaryotic NADPH cytochrome P450 reductases. The additional ability of the yeast system to perform post‐translational modifications of eukaryotic proteins is not a concern here as cytochromes P450 are generally not post‐translationally modified (Guengerich et al ., 1993). As a consequence thereof, catalytic specificity of cytochromes P450 have never been reported to be affected by post‐translational modification.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Tolbutamide is less potent than second-generation sulphonylureas such as glipizide and glyburide and it is not routinely used due to a higher incidence of adverse effects compared to newer second-generation sulfonylureas such as glyburide [1014]. Tolbutamide is mainly metabolized via methylhydroxylation by CYP2C9 to 4-OH-tolbutamide [968][969][970]1015] and thus is often used as a probe substrate for determining CYP2C9 activity (Fig. (123)).…”
Section: Tolbutamide
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…As C4H used in resveratrol pathway is a membrane-associated plant-derived P450 enzyme, which requires an electron carrier for optimal activity, we hypothesized that C4H activity may be limiting resveratrol production. Plant-derived P450s have previously been reported to poorly accept electrons directly from yeast endogenous electron carriers24. Thus, we upgraded the strain ST4978 (basic resveratrol pathway) with overexpression of cytochrome P450 reductase ( AtATR2 ) from A. thaliana or cytochrome B5 ( CYB5 ) from S. cerevisiae or both (Fig.…”
Section: Results
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…In the E. coli expression system, this is, however, easily overcome by supplementing with eukaryotic NADPH cytochrome P450 reductases. The additional ability of the yeast system to perform post‐translational modifications of eukaryotic proteins is not a concern here as cytochromes P450 are generally not post‐translationally modified (Guengerich et al ., 1993). As a consequence thereof, catalytic specificity of cytochromes P450 have never been reported to be affected by post‐translational modification.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Tolbutamide is less potent than second-generation sulphonylureas such as glipizide and glyburide and it is not routinely used due to a higher incidence of adverse effects compared to newer second-generation sulfonylureas such as glyburide [1014]. Tolbutamide is mainly metabolized via methylhydroxylation by CYP2C9 to 4-OH-tolbutamide [968][969][970]1015] and thus is often used as a probe substrate for determining CYP2C9 activity (Fig. (123)).…”
Section: Tolbutamide
mentioning
confidence: 99%